Literature DB >> 19579286

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

Akira Monji1, Takahiro Kato, Shigenobu Kanba.   

Abstract

The etiology of schizophrenia remains unclear, while there has been a growing amount of evidence for the neuroinflammation and immunogenetics, which are characterized by an increased serum concentration of several pro-inflammatory cytokines. Despite the fact that microglia comprise only <10% of the total brain cells, microglia respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia has recently been reported to be closely associatedwith microglial activation. Previous studies have shown the inhibitory effects of some typical/atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which have recently been known to cause a decrease in neurogenesis as well as white matter abnormalities in the brains of patients with schizophrenia. The microglia hypothesis of schizophrenia may shed new light on the therapeutic strategy for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579286     DOI: 10.1111/j.1440-1819.2009.01945.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  136 in total

1.  Does minocycline, an antibiotic with inhibitory effects on microglial activation, sharpen a sense of trust in social interaction?

Authors:  Motoki Watabe; Takahiro A Kato; Akira Monji; Hideki Horikawa; Shigenobu Kanba
Journal:  Psychopharmacology (Berl)       Date:  2011-09-29       Impact factor: 4.530

Review 2.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 3.  Brain imaging during the transition from psychosis prodrome to schizophrenia.

Authors:  Yoonho Chung; Tyrone D Cannon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

4.  Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function.

Authors:  Sophia Kogan; Luz H Ospina; David Kimhy
Journal:  Brain Behav Immun       Date:  2018-09-12       Impact factor: 7.217

Review 5.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

6.  Experience-Dependent Synaptic Plasticity in V1 Occurs without Microglial CX3CR1.

Authors:  Rachel W Schecter; Erin E Maher; Christina A Welsh; Beth Stevens; Alev Erisir; Mark F Bear
Journal:  J Neurosci       Date:  2017-09-26       Impact factor: 6.167

Review 7.  In vivo imaging of neuroinflammation in schizophrenia.

Authors:  Ofer Pasternak; Marek Kubicki; Martha E Shenton
Journal:  Schizophr Res       Date:  2015-06-03       Impact factor: 4.939

Review 8.  Microglia Function in Central Nervous System Development and Plasticity.

Authors:  Dorothy P Schafer; Beth Stevens
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-17       Impact factor: 10.005

9.  Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia.

Authors:  Hiroko Nomaru; Kunihiko Sakumi; Atsuhisa Katogi; Yoshinori N Ohnishi; Kosuke Kajitani; Daisuke Tsuchimoto; Eric J Nestler; Yusaku Nakabeppu
Journal:  Glia       Date:  2014-04-25       Impact factor: 7.452

10.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.